Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 128 of 151

  1. Tafenoquine

    60 DEGREES PHARMACEUTICALS, INC.

    Healthy Volunteers

    phase 2 small molecule completed

    1 trial

  2. Tafenoquine 100mg

    60 DEGREES PHARMACEUTICALS, INC.

    Chronic Babesiosis

    phase 2 small molecule active

    1 trial

  3. Tafenoquine Oral Tablet

    60 DEGREES PHARMACEUTICALS, INC.

    COVID 19 Disease

    phase 2 small molecule completed

    1 trial

  4. Tagraxofusp

    Stemline Therapeutics B.V.

    Acute Myeloid Leukemia

    phase 2 small molecule active

    1 trial

  5. Tak-228 & Tak-117

    Takeda

    Triple Negative Breast Cancer

    phase 2 small molecule completed

    1 trial

  6. Takeda's Tetravalent Dengue Vaccine Candidate (TDV)

    Takeda

    Dengue Fever

    phase 2 mab completed

    2 trials

  7. Talampanel

    Teva Pharma GmbH

    Amyotrophic Lateral Sclerosis

    phase 2 small molecule terminated

    1 trial

  8. Talampanel

    Teva Pharma GmbH

    Glioblastoma Multiforme

    phase 2 small molecule terminated

    2 trials

  9. Talampanel

    Teva Pharma GmbH

    Epilepsy

    phase 2 small molecule completed

    1 trial

  10. Talampanel

    Teva Pharma GmbH

    ALS

    phase 2 small molecule completed

    1 trial

  11. Talazoparib Tosylate

    BioMarin Pharmaceutical Australia Pty Ltd

    Advanced Breast Cancer

    phase 2 small molecule completed

    1 trial

  12. Tangweian Recipe

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Diabetic Gastroenteropathy

    phase 2 small molecule active

    1 trial

  13. Taodan Granules

    Universal Integrated

    Psoriasis Vulgaris

    phase 2 small molecule active

    1 trial

  14. Target-controlled naloxone-infusion

    BRIGHT MINDS BIOSCIENCES INC.

    Central Nervous System Sensitization

    phase 2 small molecule completed

    1 trial

  15. Tarlatamab

    Amgen

    Relapsed/Refractory Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  16. Tarlatamab, Tarlatamab

    The George Institute

    Metastaic small cell lung cancer (SCLC) and other poorly differentitated neuroendocrine carcinomas (NECs)

    phase 2 small molecule active

    1 trial

  17. Tarlatamab, Tarlatamab

    Partner Therapeutics Limited

    Patients with pretreated extensive-stage small cell lung cancer (ES-SCLC) and ECOG PS 2

    phase 2 small molecule active

    1 trial

  18. Tarperprumig Placebo, Tarperprumig

    Alexion Europe SAS

    Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis

    phase 2 small molecule active

    1 trial

  19. Tas-102(Suyuan) combined with bevacizumab

    The First People's Hospital of Lianyungang

    Colorectal Cancer

    phase 2 small molecule active

    1 trial

  20. Tasimelteon

    Vanda Pharmaceuticals Netherlands B.V.

    Jet Lag Disorder

    phase 2 small molecule completed

    1 trial

  21. Taxotere

    United Therapeutics Europe Ltd

    Breast Cancer

    phase 2 small molecule terminated

    1 trial

  22. Tazemetostat

    Eisai Co.,

    Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma

    phase 2 small molecule completed

    1 trial

  23. Tebapivat

    Agios Netherlands B.V.

    Sickle Cell Disease

    phase 2 small molecule active

    1 trial

  24. Tebapivat

    Agios Netherlands B.V.

    Myelodysplastic Syndromes

    phase 2 small molecule active

    1 trial

  25. Tecentriq 1 200 mg concentrate for solution for infusion

    Ningbo Cancer Hospital

    Muscle-invasive bladder cancer

    phase 2 small molecule active

    1 trial

  26. Tecentriq 1 200 mg concentrate for solution for infusion

    Tour Hekla

    Muscle-invasive bladder cancer

    phase 2 small molecule active

    1 trial

  27. Tecentriq 1 200 mg concentrate for solution for infusion

    The George Institute

    Locally advanced cervical cancer

    phase 2 small molecule active

    1 trial

  28. Tecentriq 1 200 mg concentrate for solution for infusion

    Wuhan Createrna Science and Technology Co., Ltd

    Limited disease small-cell lung cancer

    phase 2 small molecule active

    1 trial

  29. Tecentriq 1 200 mg concentrate for solution for infusion

    Disc Medicine

    (Diffuse) Large B-cell Lymphoma

    phase 2 small molecule active

    1 trial

  30. Tecentriq 840 mg concentrate for solution for infusion

    Hoffmann-La Roche

    Non-Small Cell Lung Cancer (NSCLC)

    phase 2 small molecule active

    1 trial

  31. Tecovirimat

    United Therapeutics Europe Ltd

    Smallpox

    phase 2 small molecule active

    1 trial

  32. Teduglutide

    Takeda

    Postoperative Fistula

    phase 2 small molecule completed

    1 trial

  33. Teduglutide (ALX-0600)

    Takeda

    Crohn's Disease

    phase 2 small molecule completed

    1 trial

  34. Tegafur Gimeracil Oteracil Potassium Capsule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Breast Cancer

    phase 2 small molecule active

    1 trial

  35. Telacebec

    BRIGHT MINDS BIOSCIENCES INC.

    Buruli Ulcer

    phase 2 small molecule active

    1 trial

  36. Telaprevir

    Vertex Pharmaceuticals (Australia) Pty.

    Chronic Hepatitis C

    phase 2 small molecule completed

    1 trial

  37. Telaprevir and Sofosbuvir

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C, Chronic

    phase 2 small molecule completed

    1 trial

  38. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Infections, Gram-Positive Bacterial

    phase 2 small molecule completed

    2 trials

  39. Telavancin

    Theravance Biopharma Ireland Umited

    Infection

    phase 2 small molecule completed

    1 trial

  40. Telavancin

    CUMBERLAND PHARMACEUTICALS INC

    Gram-Positive Bacterial Infections

    phase 2 small molecule terminated

    2 trials

  41. Telehealth Intervention

    United Therapeutics Europe Ltd

    Colorectal Cancer

    phase 2 other active

    1 trial

  42. Telisotuzumab Vedotin

    AbbVie Deutschland GmbH & Co. KG

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  43. Telisotuzumab adizutecan

    AbbVie Deutschland GmbH & Co. KG

    Colorectal Cancer

    phase 2 small molecule active

    1 trial

  44. Telisotuzumab adizutecan

    AbbVie Deutschland GmbH & Co. KG

    Locally Advanced or Metastatic Solid Tumours that harbour MET Amplification gene

    phase 2 small molecule active

    1 trial

  45. Telitacicept

    The First People's Hospital of Lianyungang

    Systemic Lupus Erythematosus

    phase 2 small molecule active

    1 trial

  46. Telitacicept

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Connective Tissue Diseases

    phase 2 mab active

    1 trial

  47. Telotristat Etiprate

    LEXICON PHARMACEUTICALS, INC.

    Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  48. Temozolomide

    PUMA BIOTECHNOLOGY, INC.

    Glioblastoma

    phase 2 small molecule active

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.